by B2i | Mar 16, 2020 | Press Releases
JUPITER, FL / March 16, 2020 / Dyadic International, Inc. (“Dyadic”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 expression system to speed up the development, lower production costs and...
by B2i | Feb 25, 2020 | Press Releases
NES-ZIONA, ISRAEL and JUPITER, FL / February 25, 2020 / Dyadic International, Inc. (‘Dyadic’) (NASDAQ:DYAI), a global biotechnology company announced today that they are joining the global fight against the coronavirus outbreak by collaborating with The...
by B2i | Feb 24, 2020 | Press Releases
Further Extends Company’s Biologic Market Opportunities JUPITER, FL / February 24, 2020 / Dyadic International, Inc. (“Dyadic”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression...
by B2i | Feb 5, 2020 | Press Releases
JUPITER, FL / February 5, 2020 / Dyadic International, Inc. (the “Company”) (NASDAQ:DYAI), today announced that its President and Chief Executive Officer, Mark Emalfarb, will be presenting at the following investor conferences: BIO CEO & Investor...
by B2i | Jan 31, 2020 | Press Releases
JUPITER, FL / January 31, 2020 / Dyadic International, Inc. (“Dyadic” or the “Company”) (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate...
